Back
Avid Bioservices Quote, Financials, Valuation and Earnings
Sponsored
CDMO
Sponsored
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Buy
69
CDMO
Avid Bioservices
Last Price:
11.93
Seasonality Move:
50.41%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.Avid Bioservices Price Quote
$11.93
-0.27 (-2.21%)
(Updated: November 14, 2024 at 5:55 PM ET)
Avid Bioservices Key Stats
Buy
69
Avid Bioservices (CDMO)
is a Buy
Day range:
$12.20 - $12.30
52-week range:
$4.07 - $12.48
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.44
P/B ratio:
13.3%
Volume:
3.3M
Avg. volume:
2.2M
1-year change:
143.03%
Market cap:
$779.6M
Revenue:
$139.9M
EPS:
$-2.27
How Much Does Avid Bioservices Make?
-
How Much Are Avid Bioservices's Sales Annually?
CDMO Revenues are $139.9M -
How Much Profit Does Avid Bioservices's Make A Year?
CDMO net income is -$140.8M
Is Avid Bioservices Growing As A Company?
-
What Is Avid Bioservices's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.06% -
What Is Avid Bioservices's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Avid Bioservices Stock Price Performance
-
Did Avid Bioservices Stock Go Up Last Month?
Avid Bioservices share price went up by 18.22% last month -
Did CDMO's Share Price Rise Over The Last Year?
CDMO share price rose by 143.03% over the past 1 year
What Is Avid Bioservices 52-Week High & Low?
-
What Is Avid Bioservices’s 52-Week High Share Price?
Avid Bioservices has traded as high as $12.48 over the past 52 weeks -
What Is Avid Bioservices’s 52-Week Low Share Price?
Avid Bioservices has traded as low as $4.07 over the past 52 weeks
Avid Bioservices Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Avid Bioservices?
-
How Much Debt Does Avid Bioservices Have?
Total long term debt quarterly is $153.9M -
How Much Cash Does Avid Bioservices Have?
Cash and short term investments quarterly total is $33.4M -
What Is Avid Bioservices’s Book Value Per Share?
Book value per share is 0.92
Is Avid Bioservices Cash Flow Positive?
-
What Is CDMO Cash Flow From Operations?
Cash flow from operations (TTM) is $7.5M -
What Is Avid Bioservices’s Cash Flow From Financing?
Cash flow from financing (TTM) is $19.6M -
What Is Avid Bioservices’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$19M
Avid Bioservices Return On Invested Capital
-
Is Management Doing A Good Job?
CDMO return on invested capital is -51.31% -
What Is Avid Bioservices Return On Assets?
ROA measures how assets are converting to revenues and is -35.62% -
What Is CDMO Return On Equity?
ROE is a measure of profitability and is -106.95%
Avid Bioservices Earnings Date & Stock Price
-
What Is Avid Bioservices's Stock Price Today?
A single share of CDMO can be purchased today for 12.20 -
What Is Avid Bioservices’s Stock Symbol?
Avid Bioservices trades on the nasdaq under the ticker symbol: CDMO -
When Is Avid Bioservices’s Next Earnings Date?
The next quarterly earnings date for Avid Bioservices is scheduled on December 6, 2024 -
When Is CDMO's next ex-dividend date?
Avid Bioservices's next ex-dividend date is November 15, 2024 -
How To Buy Avid Bioservices Stock?
You can buy Avid Bioservices shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Avid Bioservices Competitors
-
Who Are Avid Bioservices's Competitors?
Below is a list of companies who compete with Avid Bioservices or are related in some way:
Avid Bioservices Dividend Yield
-
What Is CDMO Dividend Yield?
Avid Bioservices’s dividend yield currently is 0% -
What Is Avid Bioservices’s Payout Ratio?
Avid Bioservices’s payout ratio is 0% -
When Did Avid Bioservices Last Pay A Dividend?
The latest dividend pay date is November 15, 2024 -
What Is Avid Bioservices’s Dividend Per Share?
Avid Bioservices pays a dividend of $0.00 per share
Avid Bioservices Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 43.11% |
Revenue: | 6.49% | -1.59% |
Analyst Recommendations
Buy Recommendations: | 3 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 0 |
Price Target: | 12.75 |
Upside from Last Price: | 4.51% |